In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-κB/Rel complexes

International Immunology

Volumn 12, Issue 5, 2000, Pages 613-621

  Feuillard, Jean ^b   Mémet, Sylvie ^a   Goudeau, Bertrand ^a   Lilienbaum, Alain ^a   Schmidt Ullrich, Ruth ^c   Raphaël, Martine ^b   Israël, Alain ^a  

^a INSTITUT PASTEUR   (France)

^b AVICENNE HOSPITAL   (France)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Lymphocyte; NF B Rel; Spleen; Thymus; Transgenic mice

Indexed keywords

BETA GALACTOSIDASE; FLUORESCEIN DERIVATIVE; HERMES ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR; PYRANOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; THYMOCYTE;

EID: 0343294359     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.5.613     Document Type: Article

References (42)

1. May, M. J. and Ghosh, S. 1998. Signal transduction through NF-κB. Immunol. Today 19:80.
2. Baeuerle, P. A. and Henkel, T. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141.
3. Schmidt-Ullrich, R., Mémet, S., Lilienbaum, A., Feuillard, J., Raphael, M. and Israël, A. 1996. NF-κB activity in transgenic mice: developmental regulation and tissue specificity. Development 122:2117.
4. Whiteside, S. T. and Israel, A. 1997. IκB proteins - structure, function and regulation. Semin. Cancer Biol. 8:75.
5. Grilli, M., Chiu, J. J. S. and Lenardo, M. 1993. NF-kappa-B and rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
6. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R. and Lo, D. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
7. Carrasco, D., Ryseck, R. P. and Bravo, R. 1993. Expression of relB transcripts during lymphoid organ development - specific expression in dendritic antigen-presenting cells. Development 118:1221.
8. Weih, F., Carrasco, D. and Bravo, R. 1994. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. Oncogene 9:3289.
9. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A. and Bravo, R. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80:331.
10. Schwarz, E. M., Krimpenfort, P., Berns, A. and Verma, I. M. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11:187.
11. Franzoso, G., Carlson, L., Poljak, L., Shores, E. W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Schartonkersten, T., Anver, M., Love, P., Brown, K. and Siebenlist, U. 1998. Mice deficient in nuclear factor (NF)-kappa-B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147.
12. Franzoso, G., Carlson, L., Schartonkersten, T., Shores, E. W., Epstein, S., Grinberg, A., Tran, T., Shacter, E., Leonardi, A., Anver, M., Love, P., Sher, A. and Siebenlist, U. 1997. Critical roles for the bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6:479.
13. Caamano, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventossuarez, C., Snapper, C. M. and Bravo, R. 1998. Nuclear factor (NF)-kappa-b2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185.
14. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167.
15. Kontgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R. L., Tarlinton, D. and Gerondakis, S. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Gene Dev. 9:1965.
16. Sha, W. C., Liou, H. C., Tuomanen, E. I. and Baltimore, D. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321.
17. Grumont, R. J., Richardson, I. B., Gaff, C. and Gerondakis, S. 1993. rel/NF-kB nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-Cells. Cell Growth Different. 4:731.
18. Attar, R. M., Caamano, J., Carrasco, D., Iotsova, V., Ishikawa, H., Ryseck, R. P., Weih, F. and Bravo, R. 1997. Genetic approaches to study rel/NF-κB/IκB function in mice. Semin. Cancer Biol. 8:93.
19. Fiering, S., Northrop, J. P., Nolan, G. P., Mattila, P. S., Crabtree, G. R. and Herzenberg, L. A. 1990. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T cell antigen receptor. Genes Dev. 4:1823.
20. Fiering, S. N., Roederer, M., Nolan, G. P., Micklem, D. R., Parks, D. R. and Herzenberg, L. A. 1991. Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry 12:291.
21. Berger, C. N., Tan, S. S. and Sturm, K. S. 1994. Simultaneous detection of beta-galactosidase activity and surface antigen expression in viable haematopoietic cells. Cytometry 17:216.
22. Nolan, G. P., Fiering, S., Nicolas, J. F. and Herzenberg, L. A. 1988. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl Acad. Sci. USA 85:2603.
23. Godfrey, D. I. and Zlotnik, A. 1993. Control points in early T cell development. Immunology Today 14:547.
24. Korner, M., Tarantino, N. and Debre, P. 1991. Constitutive activation of NF-kB in human thymocytes. Biochem. Biophys. Res. Commun. 181:80.
25. Grumont, R. J. and Gerondakis, S. 1994. The subunit composition of NF-kappa B complexes changes during B celi development. Cell Growth Different. 5:1321.
26. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.
27. Kistler, B., Rolink, A., Marienfeld, R., Neumann, M. and Wirth, T. 1998. Induction of NF-κB during primary B cell differentiation. J. Immunol., 160:2308.
28. Liou, H. C., Sha, W. C., Scott, M. L. and Baltimore, D. 1994. Sequential induction of NF-κB/Rel family proteins during B cell terminal differentiation. Mol. Cell. Biol. 14:5349.
29. Doi, T. S., Takahashi, T., Taguchi, O., Azuma, T. and Obata, Y. 1997. NF-κB relA-deficient lymphocytes-normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953.
30. Zelazowski, P., Carrasco, D., Rosas, F. R., Moorman, M. A., Bravo, R. and Snapper, C. M. 1997. B cells genetically deficient in the c-rel transactivation domain have selective defects in germline c-n transcription and Ig class switching. J. Immunol. 159:3133.
31. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150:4244.
32. - thymocyte differentiation. J. Immunol. 152:4783.
33. Boothby, M. R., Mora, A. L., Scherer, D. C., Brockman, J. A. and Ballard, D. W. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor NF-κB. J. Exp. Med. 185:1897.
34. Ferreira, V., Sidenius, N., Tarantino, N., Hubert, P., Chatenoud, L., Blasi, F. and Korner, M. 1999. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoeisis. J. Immunol. 162:6442.
35. Mémet, S., Laouini, D., Epinat, E., Whiteside, S. T., Goudeau, B., Philpott, D., Kayal, S., Sansonetti, P. J., Berche, P., Kanellopoulos, J. and Israel, A. 1999. IκBε-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis. J. Immunol. 163:5994.
36. Bakker, T. B., Renno, T. and Jongeneel, C. V. 1999. Impaired fetal thymocyte development after efficient adenovirus-mediated inhibition of NF-κB activation. J. Immunol. 162:3456.
37. Lowenthal, J. W., Ballard, D. W., Bohnlein, E. and Greene, W. C. 1989. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc. Natl Acad. Sci. USA 86:2331.
38. Cross, S. L., Halden, N. F., Lenardo, M. J. and Leonard, W. J. 1989. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science 244:466.
39. Lin, B. B., Cross, S. L., Halden, N. F., Roman, D. G., Toledano, M. B. and Leonard, W. J. 1990. Delineation of an enhancer-like positive regulatory element in the interleukin-2 receptor alpha-chain gene. Mol. Cell. Biol. 10:850.
40. Kuang, A. A., Novak, K. D., Kang, S. M., Bruhn, K. and Lenardo, M. J. 1993. Interaction between NF-kappa-B and serum response factor-binding elements activates an Interleukin-2 receptor alpha-chain enhancer specifically in T-lymphocytes. Mol. Cell. Biol. 13:2536.
41. Beg, A. A., Sha, W. C., Bronson, R. T. and Baltimore, D. 1995. Constitutive NF-κB activation, enhanced granulopoiesis and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736.
42. Klement, J. F., Rice, N. R., Car, B. D., Abbondanzo, S. J., Powers, G. D., Bhatt, H., Chen, C. H., Rosen, C. A. and Stewart, C. L. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341.